{"result": {"id": "c91f2efd-3815-4206-9e20-9c474e74d48d", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>CCB<|>ORGANIZATION<|>Calcium Channel Blocker, a type of medication used for treating hypertension and other cardiovascular conditions\")\n##\n(\"entity\"<|>ACEI<|>ORGANIZATION<|>Angiotensin-Converting Enzyme Inhibitor, a class of drugs used primarily for the treatment of hypertension and heart failure\")\n##\n(\"entity\"<|>ARB<|>ORGANIZATION<|>Angiotensin II Receptor Blocker, a medication used to treat high blood pressure and heart failure\")\n##\n(\"entity\"<|>利尿剂<|>ORGANIZATION<|>Diuretics, a type of medication that helps reduce blood pressure by removing excess salt and water from the body\")\n##\n(\"entity\"<|>β-受体阻滞剂<|>ORGANIZATION<|>Beta-Blockers, a class of drugs that reduce blood pressure by blocking the effects of adrenaline\")\n##\n(\"relationship\"<|>CCB<|>ACEI<|>Both CCB and ACEI are classes of drugs used for treating hypertension and other cardiovascular conditions<|>5)\n##\n(\"relationship\"<|>CCB<|>ARB<|>Both CCB and ARB are classes of drugs used for treating hypertension and other cardiovascular conditions<|>5)\n##\n(\"relationship\"<|>ACEI<|>ARB<|>Both ACEI and ARB are classes of drugs used for treating hypertension and other cardiovascular conditions<|>5)\n##\n(\"relationship\"<|>利尿剂<|>β-受体阻滞剂<|>Both Diuretics and Beta-Blockers are classes of drugs used for treating hypertension<|>5)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752165513, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 365, "prompt_tokens": 2480, "total_tokens": 2845, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 688}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 药，达到平稳控 制血压[27-31。\n　　　(3)联合治疗：对SBP≥160mmHg  和/或DBP≥  100 mmHg 、SBP高于目标血压20mmHg 和/或DBP  高于目标血压值10 mmHg或高危及以上患者，或\n\n\n单药治疗2~4周后未达标的高血压患者应联合降 压治疗，包括自由联合或单片复方制剂。对SBP≥  140 mmHg和/或DBP≥90mmHg  的患者，也可起始 小剂量联合治疗32\n　　(4)个体化治疗：根据患者合并症的不同和药 物疗效及耐受性，以及患者个人意愿或长期承受能 力，选择适合患者个体的降压药物。\n　　(5)药物经济学：高血压是终生治疗，需考虑成 本/效益。\n\n要点：降压药应用的基本原则\n●常用的五大类降压药物[钙通道阻滞剂(CCB)、血管紧张素转换 酶抑制剂(ACEI)、血管紧张素Ⅱ受体拮抗剂(ARB)、利尿剂和 β-受体阻滞剂]均可作为初始治疗用药，建议根据特殊人群的 类型、合并症，选择针对性药物个体化治疗。\n●应根据血压水平和心血管风险选择初始单药或联合治疗。\n●一般患者采用常规剂量；老年人及高龄老年人初始治疗时通常 应采用较小有效治疗剂量。根据需要，可逐渐增加剂量。\n●优先使用长效降压药物，以有效控制24h血压，更有效预防心 脑血管并发症。\n●对SBP≥160mmHg和/或DBP≥100 mmHg、SBP高于目标血压\n20 mmHg和/或DBP高于目标血压值10mmHg或高危及以上患\n者，或单药治疗未达标的高血压患者应联合降压治疗，包括自 由联合或单片复方制剂。\n●对SBP≥140mmHg和/或DBP≥90mmHg的患者，也可起始小剂 量联合治疗。\n　　2.治疗药物选择：根据适应证选择降压药 物1.93,临床常用药物和指征如表4所示。\n表4 高血压常用药物的适应证\n\n适应证\tCCB\tACEI\tARB\t利尿剂\tβ受体\n阻滞剂\n左心室肥厚\t+\t+\t+\t±\t±\n稳定性冠心病\t+\t+\t+°\t\t+\n心肌梗死后\t-a\t十\t+\t+4\t+\n心力衰竭\t_b\t+\t+\t+\t+\n心房颤动预防\t一\t+\t+\t\t\n脑血管病\t+\t+\t\t+\t±\n颈动脉内中膜增厚\t+\t±\t±\t一\t-\n蛋白尿/微量白蛋白尿\t-\t+\t+\t-\t\n肾功能不全\t±\t+\t+\t+*\t\n老年\t+\t+\t+\t+\t±\n糖尿病\t±\t+\t+\t±\t\n血脂异常\t±\t+\t+\t\t\n　　注：CCB钙通道阻滞剂(二氢吡啶类);ACEI血管紧张素转换 酶抑制剂；ARB血管紧张素Ⅱ受体拮抗剂；+适用；-证据不足或不 适用\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_5580c32cb3f6a40f4508e9c9d6ee023da5d6f2030ae049acd4d1ad5e80b11a27_v2"}